Literature DB >> 4673247

Livedo reticularis in Parkinson's disease patients treated with amantadine hydrochloride.

D E Silver, A L Sahs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4673247     DOI： 10.1212/wnl.22.7.665

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Amantadine for adynamic speech: possible benefit for aphasia?

Authors:  Anna M Barrett; Paul J Eslinger
Journal:  Am J Phys Med Rehabil       Date:  2007-08       Impact factor: 2.159

Review 2.  Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.

Authors:  D R Guay
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

3.  Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson's Disease: An Open-Label, Pragmatic Trial.

Authors:  Aryun Kim; Young Eun Kim; Ji Young Yun; Han-Joon Kim; Hui-Jun Yang; Woong-Woo Lee; Chae Won Shin; Hyeyoung Park; Yu Jin Jung; Ahro Kim; Yoon Kim; Mihee Jang; Beomseok Jeon
Journal:  J Mov Disord       Date:  2018-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.